Literature DB >> 8157734

Morphological changes in oligodendrocytes in the intact mouse optic nerve following intravitreal injection of tumour necrosis factor.

A M Butt1, H G Jenkins.   

Abstract

Intracellular dye-injection was used to determine the whole-cell morphology of oligodendrocytes in intact optic nerves of mice following intravitreal injection of tumour necrosis factor-alpha (TNF alpha) or heat-inactivated TNF alpha to act as controls. Oligodendrocytes in control nerves had a stereotypic morphology, and provided an average of 20 axons with single internodal myelin segments of around 200 microns internodal length. Oligodendrocytes with abnormal morphological features were identified 8-14 days following intravitreal injection of TNF alpha. Internodal myelin segments developed swellings along their lengths, became attenuated, and in extreme cases receded completely. This study provides a new insight into the process of demyelination, especially of the early stages which are not amenable with other techniques. Furthermore, it confirms that injection of TNF alpha into the vitreous, a fluid compartment of the CNS, instigates a sequence of events which results in oligodendrocyte disruption and demyelination. The mechanism by which intravitreally injected TNF alpha mediates these changes in optic nerve oligodendrocytes are yet unknown.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157734     DOI: 10.1016/0165-5728(94)90125-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Simulation of intra-orbital optic nerve electrical stimulation.

Authors:  M Oozeer; C Veraart; V Legat; J Delbeke
Journal:  Med Biol Eng Comput       Date:  2005-09       Impact factor: 2.602

2.  Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b.

Authors:  S Chabot; G Williams; V W Yong
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

3.  Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometry.

Authors:  Robert Cunningham; Paige Jany; Albee Messing; Lingjun Li
Journal:  J Proteome Res       Date:  2013-01-11       Impact factor: 4.466

Review 4.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 5.  Are current immunological concepts of multiple sclerosis reflected by the immunopathology of its lesions?

Authors:  H Lassmann; K Vass
Journal:  Springer Semin Immunopathol       Date:  1995

6.  Modelling analysis of human optic nerve fibre excitation based on experimental data.

Authors:  S Parrini; J Delbeke; V Legat; C Veraart
Journal:  Med Biol Eng Comput       Date:  2000-07       Impact factor: 2.602

Review 7.  Strategies for treatment in Alexander disease.

Authors:  Albee Messing; Christine M LaPash Daniels; Tracy L Hagemann
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

8.  Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor.

Authors:  C P Genain; T Roberts; R L Davis; M H Nguyen; A Uccelli; D Faulds; Y Li; J Hedgpeth; S L Hauser
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

9.  Nogo-A-targeting antibody promotes visual recovery and inhibits neuroinflammation after retinal injury.

Authors:  Julius Baya Mdzomba; Sandrine Joly; Léa Rodriguez; Ali Dirani; Patricia Lassiaz; Francine Behar-Cohen; Vincent Pernet
Journal:  Cell Death Dis       Date:  2020-02-06       Impact factor: 8.469

10.  Structural myelin defects are associated with low axonal ATP levels but rapid recovery from energy deprivation in a mouse model of spastic paraplegia.

Authors:  Andrea Trevisiol; Kathrin Kusch; Anna M Steyer; Ingo Gregor; Christos Nardis; Ulrike Winkler; Susanne Köhler; Alejandro Restrepo; Wiebke Möbius; Hauke B Werner; Klaus-Armin Nave; Johannes Hirrlinger
Journal:  PLoS Biol       Date:  2020-11-16       Impact factor: 8.029

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.